Profile data is unavailable for this security.
About the company
KBR, Inc. is engaged in delivering science, technology and engineering solutions to governments and companies around the world. The Company's Government Solutions segment provides full life-cycle support solutions to defense, intelligence, space, aviation and other programs and missions for military and other government agencies primarily in the United States, United Kingdom, and Australia. The Company’s Sustainable Technology Solutions segment is anchored by its portfolio of over 80 proprietary, sustainability-focused process technologies that accelerate and enable energy transition across the industrial base in four primary verticals: ammonia/syngas, chemical/petrochemicals, clean refining and circular process/circular economy solutions. The segment also provides highly synergistic services, including advisory and consulting. The Company provides services to a diverse customer base, including domestic and foreign governments and commercial and industrial companies.
- Revenue in USD (TTM)6.96bn
- Net income in USD-265.00m
- Incorporated2006
- Employees34.00k
- LocationKBR IncSUITE 3400, 601 JEFFERSON STREETHOUSTON 77002United StatesUSA
- Phone+1 (713) 753-3834
- Fax+1 (302) 655-5049
- Websitehttps://www.kbr.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals PLC | 3.83bn | 414.83m | 6.68bn | 2.80k | 17.51 | 1.78 | 6.32 | 1.74 | 6.12 | 6.12 | 53.20 | 60.03 | 0.345 | 0.6645 | 5.65 | 1,369,359.00 | 3.76 | 1.48 | 4.23 | 1.62 | 88.64 | 88.79 | 10.90 | 4.26 | 1.85 | 2.06 | 0.6048 | 0.00 | 4.78 | 15.19 | 285.14 | -1.49 | -20.04 | -- |
| Vaxcyte Inc | 0.00 | -402.27m | 6.77bn | 254.00 | -- | 4.80 | -- | -- | -4.07 | -4.07 | 0.00 | 13.01 | 0.00 | -- | -- | 0.00 | -33.33 | -34.22 | -36.11 | -37.21 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -80.00 | -- | 107.28 | -- |
| Exelixis Inc | 1.83bn | 207.77m | 6.93bn | 1.31k | 35.34 | 3.06 | 29.70 | 3.79 | 0.6472 | 0.6472 | 5.69 | 7.48 | 0.6087 | 2.87 | 8.09 | 1,397,105.00 | 6.91 | 8.86 | 7.85 | 9.91 | 96.04 | 96.30 | 11.35 | 15.43 | 3.30 | -- | 0.00 | 0.00 | 13.60 | 16.47 | 13.98 | -21.34 | 3.98 | -- |
| Cytokinetics, Inc. | 7.53m | -526.24m | 7.10bn | 423.00 | -- | -- | -- | 943.41 | -5.45 | -5.45 | 0.078 | -3.80 | 0.0082 | -- | 10.53 | 17,801.42 | -57.23 | -43.14 | -63.72 | -47.22 | -- | -- | -6,988.63 | -540.47 | -- | -16.52 | 2.66 | -- | -92.04 | -24.89 | -35.30 | -- | 9.76 | -- |
| Bellring Brands Inc | 1.73bn | 165.20m | 7.11bn | 420.00 | 43.88 | -- | 33.75 | 4.10 | 1.24 | 1.24 | 12.99 | -2.19 | 2.39 | 5.89 | 9.62 | 4,129,762.00 | 22.78 | 18.89 | 29.01 | -- | 32.08 | 32.44 | 9.52 | 10.10 | 1.71 | 4.39 | 1.53 | 0.00 | 21.53 | 15.03 | 101.09 | 13.80 | -18.48 | -- |
| Viking Therapeutics Inc | 0.00 | -85.90m | 7.33bn | 27.00 | -- | 19.10 | -- | -- | -0.9153 | -0.9153 | 0.00 | 3.48 | 0.00 | -- | -- | 0.00 | -31.99 | -21.91 | -34.64 | -23.04 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.73 | -- | -- | -- |
| Intra-Cellular Therapies Inc | 464.37m | -139.67m | 7.42bn | 610.00 | -- | 12.50 | -- | 15.99 | -1.46 | -1.46 | 4.84 | 6.14 | 0.6262 | 1.90 | 4.91 | 761,262.30 | -18.84 | -38.27 | -21.89 | -42.77 | 92.73 | -- | -30.08 | -128.42 | 5.31 | -- | 0.00 | -- | 85.51 | -- | 45.49 | -- | -7.22 | -- |
| Cerevel Therapeutics Holdings Inc | 0.00 | -432.84m | 7.55bn | 334.00 | -- | 11.20 | -- | -- | -2.66 | -2.66 | 0.00 | 3.71 | 0.00 | -- | -- | 0.00 | -38.29 | -- | -41.29 | -- | -- | -- | -- | -- | -- | -- | 0.3337 | -- | -- | -- | -23.14 | -- | -- | -- |
| KBR Inc | 6.96bn | -265.00m | 8.38bn | 34.00k | -- | 6.08 | -- | 1.20 | -2.03 | -2.03 | 50.04 | 10.24 | 1.25 | -- | 5.91 | 204,588.20 | -4.69 | 0.4725 | -6.77 | 0.6678 | 14.05 | 12.18 | -3.75 | 0.4122 | -- | 1.14 | 0.5679 | 340.00 | 5.97 | 7.20 | -240.21 | -- | 36.31 | 11.03 |
| Roivant Sciences Ltd | 123.24m | 4.35bn | 8.41bn | 904.00 | 2.06 | 1.38 | 1.97 | 68.26 | 5.07 | 5.23 | 0.1597 | 7.57 | 0.0259 | -- | 3.57 | 136,328.50 | 89.08 | -- | 105.17 | -- | 87.57 | -- | 3,439.02 | -- | 27.77 | -- | 0.0638 | -- | 10.84 | -- | -32.93 | -- | -- | -- |
| Legend Biotech Corp (ADR) | 285.14m | -518.25m | 8.88bn | 1.80k | -- | 7.10 | -- | 31.15 | -2.95 | -2.95 | 1.62 | 6.88 | 0.1794 | 9.68 | 5.70 | 158,412.80 | -32.60 | -37.71 | -38.89 | -47.19 | 49.42 | -- | -181.75 | -286.51 | 6.83 | -24.23 | 0.208 | -- | 143.70 | 42.15 | -16.11 | -- | 1.57 | -- |
| Repligen Corp | 638.76m | 41.58m | 8.99bn | 1.78k | 223.36 | 4.55 | 81.97 | 14.07 | 0.7207 | 0.7207 | 11.27 | 35.35 | 0.2388 | 1.47 | 5.31 | 358,252.40 | 1.55 | 4.38 | 1.74 | 5.03 | 49.35 | 55.43 | 6.51 | 15.91 | 5.75 | -- | 0.2272 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| BIO-TECHNE Corp | 1.14bn | 224.12m | 9.86bn | 3.05k | 45.25 | 5.02 | 29.49 | 8.61 | 1.39 | 1.39 | 7.09 | 12.50 | 0.4495 | 2.21 | 5.84 | 375,409.50 | 8.80 | 9.57 | 9.28 | 10.20 | 67.13 | 67.35 | 19.58 | 21.91 | 3.03 | 18.86 | 0.1854 | 24.19 | 2.81 | 12.07 | 4.88 | 25.13 | 12.81 | 0.00 |
| Catalent Inc | 4.10bn | -1.30bn | 10.11bn | 17.80k | -- | 2.75 | -- | 2.47 | -7.18 | -7.18 | 22.52 | 20.37 | 0.3878 | 4.09 | 3.00 | 230,224.70 | -12.32 | 2.88 | -14.02 | 3.26 | 17.94 | 31.03 | -31.77 | 6.35 | 1.71 | -0.625 | 0.5758 | 0.00 | -11.22 | 11.59 | -153.00 | -- | 26.69 | -- |
Data as of Apr 18 2024. Currency figures normalised to KBR Inc's reporting currency: US Dollar USD
49.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 18.07m | 13.38% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 12.87m | 9.53% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 11.14m | 8.25% |
| Massachusetts Financial Services Co.as of 31 Dec 2023 | 5.31m | 3.93% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 3.93m | 2.91% |
| Invesco Advisers, Inc.as of 31 Dec 2023 | 3.68m | 2.73% |
| Frontier Capital Management Co. LLCas of 31 Dec 2023 | 3.25m | 2.41% |
| Franklin Mutual Advisers LLCas of 31 Dec 2023 | 3.08m | 2.28% |
| Permian Investment Partners LPas of 31 Dec 2023 | 2.77m | 2.05% |
| Viking Global Investors LPas of 31 Dec 2023 | 2.63m | 1.95% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
